Latham & Watkins advised KoBold on the round. KoBold Metals has announced a $195 million funding round, bringing the company’s valuation to over $1 billion and...
KoBold Metals’ $195 Million Funding Round
NewLimit’s $40 Million Series A Funding Round
Latham & Watkins represented NewLimit in the financing. NewLimit has announced that it has raised $40 million in a Series A funding round from Dimension, Founders Fund,...
Sonoma Biotherapeutics’ Collaboration Agreement with Regeneron Pharmaceuticals
Latham & Watkins advised Sonoma Biotherapeutics on the transaction. Sonoma Biotherapeutics, Inc. and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a collaboration to apply their scientific and...
Medallion’s $35 Million Series C Financing
Latham & Watkins represented Medallion in the financing. Medallion, the modern provider management platform, has announced US$35 million in Series C funding, raising its total funding...
Xepelin’s $111 Million Series B Financing
Gunderson Dettmer represented Xepelin on the deal. Latham & Watkins and Barros & Errázuriz and Ritch, Mueller y Nicolau represented Avenir. Carey advised Manutara Ventures and...
Clarify Health’s $150 Million Series D Financing
Latham & Watkins represented Clarify Health in the transaction. Clarify Health, a leading cloud analytics and value-based payments platform company, has announced that it secured US$150...
Kobold Metals’ $192.5 Million Series B Financing
Latham & Watkins represented Kobold Metals in the transaction. Kobold Metals, an AI powered mineral exploration company, has announced it has raised US$192.5 million in its...
OpenSea’s $300 Million Series C Financing
Latham & Watkins represented OpenSea in the transaction. OpeanSea, an NFT marketplace, raised US$300 million in its Series C financing resulting in a US$13.3 billion post...